PERSPECTIVES ON DRUGS Emergency health consequences of cocaine use in Europe

Similar documents
Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index

Drug-related deaths and deaths among drug users in Ireland figures from the National Drug-Related Deaths Index

Overview of drug-induced deaths in Europe - What does the data tell us?

Estimating the annual number of deaths among problem opioid users in Europe ( 1 )

Professor Paul I Dargan

The accident injuries situation

Information & statistics related to alcohol & drug misuse and community pharmacybased brief advice & intervention

The National Methamphetamine Symposium

Acute Drug Toxicity Data

The causes of misuse:

Trends in injecting drug use in Europe

Non-prescription Drugs. Wasted Youth

Statistics on Drug Misuse: England, 2008

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS

World Drug Report 2017

Evidence-based interventions for managing illicit drug dependence

Presented at: Annual expert meeting on Drug-related deaths (DRD) and Drug-Related infectious diseases (DRDI), October 2014, EMCDDA, Lisbon

JSNA Substance Misuse

Substance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %

Drug related hospital stays in Australia

Global drug trends and sustainable development

Polysubstance Use & Medication-Assisted Treatment

Statistics on Drug Misuse: England, 2007

Substance Misuse and Abuse

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

Substance Misuse in Older People

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

Common poly-substance abuse: MDMA, Ketamine, & Methamphetamine Clinical detection and management

Missed opportunities for early intervention in first episode psychosis in methamphetamine users. Dr Julia Lappin, NDARC & UNSW School of Psychiatry

Cocaine. Module 6. ALLIED TRADES ASSISTANCE PROGRAM Preventative Education: Substance Use Disorder

Cannabis Use among People Entering Drug Treatment in Europe: A Growing Phenomenon?

PERSPECTIVES ON DRUGS Preventing overdose deaths in Europe

reduce your risk from stimulants 19 ways to stimulants harm reduction advice

Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe

Drug-related hospital stays in Australia

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Alcohol - an issue for older women too! Rolande Anderson-Project Director ICGP Helping Patients with Alcohol Problems

Drug-related hospital stays in Australia

Concurrent Disorders

SOCI221. Session 11. Crisis and Trauma Issues: Alcohol and other drugs; Eating disorders and Referrals. Department of Social Science

Statistics on Drug Misuse: England, 2012

Substance Misuse and Abuse

Glencoe Health. Lesson 3 Psychoactive Drugs

FOLLOW DIRECTIONS. How to Use Methadone Safely. U.S. Department of Health & Human Services

Annual report 2012: the state of the drugs problem in Europe

Methamphetamine Abuse During Pregnancy

In order to do this we want a consistent approach from Sheffield agencies to maximise the impact of this work.

INTRAVENOUS INJECTING DRUG USE.

Insights into shared and specific features of intensive drug use in Europe

The burden caused by alcohol

Welcome! Today we ll discuss some of the important relationships between physical health and substance use that clinicians may encounter as they apply

Tramadol-related deaths

Amy Eisenhauer Developed for Pulse Check 2016

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

COMPETENCY. Presented by: Hon. Candace Cooper (Ret.) Association of Corporate Counsel. Wednesday, January 14, 2015

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

The Scottish Burden of Disease Study, Drug use disorders technical overview

Evidence table for systematic reviews

OVERDOSE DEATHS IN AUSTRALIA COCAINE AND METHAMPHETAMINE MENTIONS IN ACCIDENTAL DRUG-INDUCED DEATHS IN AUSTRALIA,

EMCDDA looks behind rising numbers of young people in cannabis treatment

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications

PERSPECTIVES ON DRUGS Characteristics of frequent and high-risk cannabis users

Live A Life Above The Influence!

1 STUDYING THE STUDY DRUG: ADDERALL. iaddiction.com

ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS

NATIONAL AND REGIONAL ESTIMATES OF THE PREVALENCE OF OPIATE AND/OR CRACK COCAINE USE : A SUMMARY OF KEY FINDINGS

Ethics and. Diagnosis. John Lisy. Executive Director - Shaker Heights Youth Center Treasurer NAADAC LICDC-CS, OCPS II, LISW-S, & LPCC-S

Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April March 2012

DRUG - RELATED DEATH

Drug Misuse Research Division

teen drug use Percent of 12th-graders Who Used A Substance in the Past Month (Type of Drug & Prevalence): 13% 33% 11% 23%

S. Darke, S. Kaye, R. McKetin & J. Duflou. Physical and psychological harms of psychostimulant use. NDARC Technical Report No. 286

Drug Related Deaths in Highland

The costs of traumatic brain injury. Michael Parsonage February 2017

ORGANIZATION OF AMERICAN STATES

Drug Related Admissions to Intensive Care: The Role of Illicit Drugs and Self Poisoning

Co-ordination, monitoring and evaluation of drug policies. Bob Keizer. Senior Drug Policy Advisor. Trimbos-instituut

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

Solving the ecstasy puzzle case study in the Netherlands

Veteran s Integrative Pain (VIP) Center: A program for high risk patients on chronic opioids

The drugs situation in Ireland: an overview of trends from 2005 to 2015.

Chapter 23. Medicines and Drugs

ALCOHOL RELATED DEATHS REGISTERED IN NORTHERN IRELAND ( )

National Drug-Related Deaths Index

Social and Psychological Back-Ground of Drug Addicts Interviewed in Dublin

Welcome! Today we ll discuss some of the important relationships between mental and physical health that clinicians may encounter as they apply the

ED-SCANS: OVERALL DECISION SUPPORT ALGORITHM. Is This Strictly a Pain Episode? Decision 7: Referrals

Questions for first-stage health assessment at reception into prison

Substance Abuse Trends in Maine Epidemiological Profile 2013

Updated: 08/2017 DMMA Approved: 11/2017

Substance Misuse and The Heart. Rory O Hanlon ICGP November 2011

Harms and harm reduction workbook. Country X

Cannabis trends in France TDI data

PERSPECTIVES ON DRUGS Preventing overdose deaths in Europe

Summary. 10 The 2007 ESPAD Report

Substance Abuse Trends in Maine. Epidemiological Profile Central District

Annual report 2009: the state of the drugs problem in Europe

Managing drug misuse in pregnancy and beyond

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Transcription:

UPDATED 16. 5. 2014 PERSPECTIVES ON DRUGS Emergency health consequences of cocaine use in Europe Every year, several thousands of cocainerelated emergencies are reported in Europe, along with hundreds of cocainerelated deaths. The types of cocainerelated problems reported are wideranging and the relatively high prevalence of cocaine use in the general population means that there is likely to be a significant impact on overall public health. The last decade has seen cocaine establish itself as the most commonly used illicit stimulant drug in Europe, with an estimated 2.5 million young adults (aged 15 34) using the drug in the last year. Overall, powder cocaine is the most common form of the drug used, and high levels of use tend to be concentrated in a relatively small number of western European countries (e.g. Denmark, Spain, Ireland, Italy, the United Kingdom). Crack cocaine use and its associated problems, is reported by a limited number of countries, and often overlaps with the use of heroin and other substances. Although many users of cocaine will not experience problems, a minority will suffer acute adverse effects that may result in them receiving help from emergency services. I Acute emergencies: a window on cocaine-related problems Full edition of this article with interactive features available online at emcdda.europa.eu/topics/ pods/cocaine-related-emergencies A recent EMCDDA study provided a first overview of cocainerelated emergency episodes reported in Europe. The data were mostly collected retrospectively, from on-going monitoring systems in place in hospitals, at either local or national level. The results highlight the fact that countries were using a range of different definitions and data sources to monitor cocaine-related emergencies at the national level (Mena et al., 2012). Overall, however, around two-thirds or more of all the reported cases involved males, although there was variation between countries. Building on the study methodology, countries have provided updates with their most recent data on cocaine episodes. According to this, Spain reported the highest number of emergency cases (2 386 in 2011),

followed by the United Kingdom (2 247 hospital discharges in 2010/2011), Italy (1 898 hospital admissions in 2009), the Netherlands (896 hospital admissions in 2011) and Denmark (150 patients registered at emergency departments in 2011). Data is also available for the UK (England) with 662 hospital discharges reported in 2011/12. Although the proportion of all drug-related hospital emergency episodes that are related to cocaine varies between countries, depending to a large extent on the prevalence of cocaine use, in Spain, for example, half of all drug-related hospital emergencies in 2010 were reportedly cocaine-related. The numbers of cocaine-related problems reported in Europe are, for a number of reasons, likely to be underestimated. One reason for this is that cases may be coded according to the symptoms (e.g. chest pain, convulsions, stroke etc.) rather than as being due to cocaine. In addition, in some countries, hospital data are only available for patients who are admitted (inpatient stay). A study in one London hospital found that around 50% of those who presented to the emergency department with cocaine (and all recreational drug-related) toxicity were admitted to hospital. The other 50% of cases who are discharged were not captured by the system. In this case the hospital inpatient data would grossly underestimate the overall prevalence of patients presenting with acute cocainerelated toxicity (Wood, 2010). I Trends in cocaine-related emergencies Both the differences in type of data source used to monitor cocaine-related emergency episodes and limitations of the data make comparison between and even within countries difficult. Nevertheless, as the case definitions and collection systems have remained unchanged over time in most countries; this allows analysis of time trends. Taking a long-term perspective, there has been a two- to threefold increase in the number of cocaine-related emergency episodes reported since the end of the 1990s in some European countries. In Spain and the United Kingdom, these increases appear to have peaked around 2007 08 and have subsequently dropped. The overall trend is consistent with changing prevalence of use among the young population; with rates of cocaine-related deaths; and with the number of people entering treatment with cocaine as the primary drug. The picture varies between countries, however (see Figures 1 4 below). Figure 1: Emergency cases due to an acute reaction following the use of psychoactive substances with a direct relation to cocaine in Spain, 1999 2011 Figure 2: Cocaine related poisonings: inpatient admissions in England ( 1 ), 1999/2000 2011/12 Sources: National report 2011 and National focal point 2013, Spain. ( 1 ) Data from England are shown instead of data for the whole UK as they provide the longest trend data. They refer to Finished Consultant Episodes with a primary diagnosis of cocaine poisoning. The figure does not include those who are discharged directly from the emergency department, nor those with a primary diagnosis of mental and behavioural disorders due to the use of cocaine. Sources: UK National focal point. Based on the National Health Service Information Centre http://www.hscic.gov.uk/searchcatalogue?q=title%3a%22hospital+episod e+statistics%2c+admitted+patient+care+-+england%22&sort=relevance&size= 20&page=1#top

Figure 3: Hospital admissions due to emergencies related to cocaine use or dependence (primary or secondary diagnosis) in the Netherlands, 1999 2011 Figure 4: Patients registered at emergency departments in Denmark due to intoxications and poisonings caused by cocaine, 1999 2011 Sources: National Drug Monitor, Trimbos-instituut (the Netherlands Institute of Mental Health and Addiction), Utrecht, 2011. National report 2011: Netherlands. Sources: National report 2011, Denmark. I Acute cocaine-related health problems Hospital emergency admissions related to cocaine use involve clients presenting with a range of physical and neuropsychiatric adverse effects (see box A vignette of typical victims of a cocaine-related emergency in northern Italy ). Symptoms associated with acute cocaine-related cases commonly include agitation, anxiety, aggression and seizures. A further acute and potentially life-threatening complication can be hyperthermia (a very elevated body temperature). Acute psychiatric symptoms can include suicidal thoughts and psychosis. The cardiac effects of cocaine may range from tachycardia (fast heart rate), hypertension (high blood pressure), arrhythmias (abnormal heart rhythm) to chest pain due to acute coronary syndrome and myocardial infarction. Chronic cocaine use has been associated with an increased risk of coronary artery disease, cardiomyopathy (deterioration in heart muscle function) and stroke (Dinis-Oliveira, 2012). Cocaine use and alcohol use, in particular heavy episodic drinking, are often associated, and this may be factor in some emergency admissions linked with violence or traffic accidents (EMCDDA, 2012). I Cocaine-related deaths: under-reported and underestimated While many cocaine-related emergencies will not result in serious or long-term health problems, at the other end of the scale some European countries do report significant numbers of cocaine-related deaths. It is likely that many deaths go unreported and that overall cocaine-related mortality is underestimated. Also the type of cases reported, the recording practices and the sources used vary considerably between countries. Nevertheless, in Europe, the majority of cocainerelated deaths are reported in Spain (almost 300 cases of cocaine-related deaths in 2010) and the United Kingdom (152 cases with mentions of cocaine on the death certificate in 2011), also mirroring the relatively high prevalence of use in these countries. In addition, some 20 to 50 cases are reported annually from other European countries (Corkery, 2012). Recent studies suggest that mortality can be four to eight times higher among cocaine users than age and sex peers in the general population (Degenhardt et al., 2011; de la Fuente et al., 2013). Most of these cocaine-related deaths are among young males, many of whom have used cocaine with opioids and a range of other drugs. Most cases involved overdose, but a minority die of less specific causes, for example cardiovascular problems. In some cases, the concomitant use of other drugs makes it difficult to establish a causal link with cocaine.

I Conclusion and public health implications There is no doubt that the use of cocaine currently places a considerable burden on emergency services in Europe; however, the presentation of cocaine users at emergency departments also offers an opportunity for services to make contact with a group that may otherwise be hard to reach. There is clearly some potential for early identification, assessment and referral opportunities for many cocaine users who might otherwise be overlooked. The benefit of using hospital emergency data for monitoring acute problems associated with cocaine use is relatively clear and further work is needed to harmonise and improve this data set. In future, it will also be important to explore how this data source might be used to monitor acute toxicity and health problems associated with the use of other drugs, including amphetamines, prescription opioids and new psychoactive substances. I Facts and figures 2.2 million young adults (aged 15 34), or an average of 1.7%, used cocaine last year. Relatively high levels of cocaine use among young adults (between 2.4% and 3.6%) were reported in Denmark, Ireland, Spain and the United Kingdom. 22 years is the mean age at first use of cocaine, for the cocaine clients entering treatment in Europe. Their mean age at entering treatment is 33 years and 85% are male. Two- to three-fold: the increase in the number of cocainerelated episodes reported since the end of the 1990s in some countries. 2007 2008 were the peak years for reports of cocainerelated emergencies in Spain and the United Kingdom. 27% of the regular cocaine users (aged 18 20) in a recent Spanish study, who were not regular heroin users, had experienced acute cocaine toxicity symptoms during the last year. One-third of these (35%) presented symptoms of psychosis (hallucinations or delirium) and more than 50% reported chest pain (Santos, 2012). A vignette of typical victims of a cocaine-related emergency in northern Italy This vignette of typical victims of a cocaine-related emergency in northern Italy ( 1 ) is based on Pavarin et al., 2011. Hospitals based in the Emilia-Romagna region of northern Italy typically see two types of cocaine user presenting at emergency departments. The more common could be described as non-dependent cocaine users, probably using the drug recreationally. These represent around 80% of all cocaine-related cases. The remaining 20% of cases may be described as involving dependent concurrent users of cocaine and opiates. A typical non-dependent emergency department visitor would be a man in his early thirties. He would have presented at the emergency department during the weekend, either at night or in the early hours of the morning (between 5 p.m. and 8 a.m.). He would have used cocaine more than 12 hours before presenting at the hospital, and may have used other substances alongside cocaine, particularly alcohol and cannabis. He would be suffering from one or more psychiatric symptom, in particular anxiety, agitation and paranoia. In addition, he may be feeling unwell and weak, with other symptoms including palpitations, chest pain and dyspnoea (difficulty in breathing), headache, vomiting and abdominal pain. He may also have presented with injuries (mainly unintentional) caused by violent behaviour or a road traffic accident. By contrast, a typical dependent cocaine user visiting the emergency department would be a slightly older man, in his mid-thirties. He would have presented either at night or in the early hours of the morning, and not necessarily at the weekend. He would be using opiates regularly, together with cocaine and other drugs. With regard to symptoms, he is likely to be anxious, agitated and confused and might have hallucinations. He might present with palpitations, chest pain, vomiting and abdominal pain. Dyspnoea would be slightly more frequent than among non-dependent cocaine users and might be linked with smoking crack cocaine. He is more likely than a non-dependent user to present with complications of HIV or hepatitis C virus infection, which is linked with his long-term drug injection behaviour. ( 1 ) This case vignette is a summary of an aggregate profile, derived from the characteristics of individual cases recorded in a study carried out in 23 different emergency centres in the Emilia-Romagna region of northern Italy. This study reviewed a consecutive series of 743 patients seen between January 2007 and December 2008 for their cocaine-related medical and trauma problems. This vignette is presented to give an insight and may not be representative of other cocaine user populations.

References I Corkery J.M. (2012), Analysis of the data sources, numbers and characteristics of cocaine-related DRD cases reported in Special Mortality Registries, or eventually in General Mortality Registries (GMR) when necessary, pp. 28. Available with appendices from http://www.emcdda.europa.eu/themes/key-indicators/drd I Degenhardt, L., Singleton, J., Calabria, B., McLaren, J., Kerr, T., Mehta, S., et al. (2011), Mortality among cocaine users: a systematic review of cohort studies, Drug and Alcohol Dependence 113 (2 3), pp. 88 95. I Dinis-Oliveira, R. J., Carvalho, F., Duarte, J. A., Proenca, J. B., Santos, A. and Magalhaes, T. (2012), Clinical and forensic signs related to cocaine abuse, Current Drug Abuse Review 5(1), pp. 64 83. I EMCDDA (2012), Driving under the influence of drugs, alcohol and medicines in Europe: findings from the DRUID project, Publications Office of the European Union, Luxembourg, pp. 1 57. I de la Fuente, L., Molist, G., Espelt, A., Barrio, G., Guitart, A., Bravo, M.J., et al. (2013), Mortality risk factors and excess mortality in a cohort of cocaine users admitted to drug treatment in Spain, Journal of Substance Abuse Treatment 46(2), pp. 219 26. I Mena, G., Giraudon, I., Alvarez, E., Corkery, J. M., Matias, J. et al. (2013), Cocainerelated health emergencies in Europe: a review of sources of information, trends and implications for service development, European Addiction Research 19(2), pp. 74 81. I Pavarin, R., Lugoboni, F., Mathewson, S., Ferrari, A. M., Guizzardi, G. and Quaglio, G. (2011), Cocaine-related medical and trauma problems: a consecutive series of 743 patients from a multicentre study in Italy, European Journal of Emergency Medicine 18(4), pp. 208 214. I Santos, S., Brugal, M. T., Barrio, G., Castellano, Y., Domingo-Salvany, A. et al. (2012), Assessing the effect of patterns of cocaine and alcohol use on the risk of adverse acute cocaine intoxication, Drug and Alcohol Review 31(4), pp. 439 446. I Wood, D. M. and Dargan, P. I. (2010), Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective, British Journal of Clinical Pharmacology 69(5), pp. 443 447. I Interactive element: video Video: cocaine-related emergencies available on the EMCDDA website: emcdda.europa.eu/topics/pods/cocaine-related-emergencies